Meningiomas are the most common intracranial tumors. Yet, only few controlled clinical trials
have been conducted to guide clinical decision making, resulting in variations of …

Peptide receptor radionuclide therapy (PRRT) has over the last two decades emerged as a
very promising approach to treat neuroendocrine tumors (NETs) with rapidly expanding …

Purpose To provide practice guideline/procedure standards for diagnostics and therapy
(theranostics) of meningiomas using radiolabeled somatostatin receptor (SSTR) ligands …

The Simpson grading scale, developed in 1957 by Donald Simpson, has been considered
the gold standard for defining the surgical extent of resection for WHO grade I meningiomas …

Purpose Radiation treatment planning for meningiomas traditionally involves magnetic
resonance imaging (MRI) contrast enhanced images to define residual tumor. However, the …

Somatostatin receptor (SSTR) 2, widely expressed in meningioma, is a G-protein-coupled
receptor and can be activated by somatostatin or its synthetic analogs. SSTR2 is therefore …

Simple Summary [68Ga] Ga-DOTA-SSTR PET imaging has recently been introduced in the
management of patients with brain tumors, mostly meningiomas and pituitary adenomas or …

Abstract Multiple approaches with [68Ga]-DOTATATE, a somatostatin analog PET
radiotracer, have demonstrated clinical utility in evaluation of meningioma but have not been …

Background Meningiomas express high levels of somatostatin receptor 2 (SSTR2). SSTR2-
targeted PET imaging with [68Ga]-DOTATATE can aid with distinguishing residual …

BACKGROUND Surgeon's intraoperative estimation of meningioma extent of resection
(Simpson Grade, SG) is widely used as a prognostic factor for recurrence. However, the …